Dying or Lying? For-Profit Hospices and End of Life Care
The Medicare hospice program is intended to provide palliative care to terminal patients, but patients with long stays in hospice are highly profitable, motivating concerns about overuse among the Alzheimer’s and Dementia (ADRD) population in the rapidly growing for-profit sector. We provide the first causal estimates of the effect of for-profit hospice on patient spending using the entry of for-profit hospices over twenty years. We find hospice has saved money for Medicare by offsetting other expensive care among ADRD patients. As a result, policies limiting hospice use including revenue caps and anti-fraud lawsuits are distortionary and deter cost-saving admissions.
-
-
Copy CitationJonathan Gruber, David H. Howard, Jetson Leder-Luis, and Theodore L. Caputi, "Dying or Lying? For-Profit Hospices and End of Life Care," NBER Working Paper 31035 (2023), https://doi.org/10.3386/w31035.Download Citation
Published Versions
Jonathan Gruber & David H. Howard & Jetson Leder-Luis & Theodore L. Caputi, 2025. "Dying or Lying? For-Profit Hospices and End-of-Life Care," American Economic Review, American Economic Association, vol. 115(1), pages 263-294, January, DOI: 10.1257/aer.20230328. citation courtesy of 
Jonathan Gruber & David H. Howard & Jetson Leder-Luis & Theodore L. Caputi, 2025. "Dying or Lying? For-Profit Hospices and End-of-Life Care," American Economic Review, vol 115(1), pages 263-294.
Related
Mentioned in the News
More from the NBER
In addition to working papers, the NBER disseminates affiliates’ latest findings through a range of free periodicals—the NBER Reporter, the NBER Digest, the Bulletin on Health, the Bulletin on the Economics of Alzheimer's, and the Bulletin on Entrepreneurship—as well as research spotlights, lectures, and panel videos.
